MIT Engineers

SME investing minus the circus. IPOs, OFS & business models. Market survivor. Not SEBI registered—just trying to be less wrong than yesterday.

[MIT Engineers @MitEngineers]

Vaibhav Vyapaar (LoanFront) 👀 — Interesting Bulk Deals!

🟢 Capfront Technologies (Promoter??) — Bought 5.40 lakh shares @ ₹53.12.

🟢 Getfive Opportunity Fund-I — Bought 5.80 lakh shares @ ₹52.90.

🔴 Innovative Vision Fund — Sold 5.76 lakh shares.

Why is this interesting?

Capfront Technologies is the promoter of Vaibhav Vyapaar, the company behind LoanFront, its digital lending platform.

And Getfive is the IPO's merchant banker — its associated fund has now bought 5.80 lakh shares in the market.

Promoter buying + merchant-banker's associated fund buying, while another fund sells.

Coincidence or confidence? 👀

Disclaimer: This is a preliminary observation based on publicly available information and bulk-deal data. If any detail is incorrect, please correct me.
Personal observation, not investment advice. DYDD.

[MIT Engineers @MitEngineers]

SME IPO carnage has hit early this time. Over the last 2 years, the bloodbath has typically happened in March. This time, the warning signs are appearing much earlier.

Recent SME shareholding patterns suggest QIB & anchor holdings declining, with retail and HNIs absorbing the supply.

Anchors are fine, but why a separate HNI quota if the endgame is to pass shares to retail/HNIs? QIBs with no lock-in only add to selling pressure.

Time to rethink SME IPO allocation before the next March carnage arrives early.

[MIT Engineers @MitEngineers]

@RajStockWatch Even Carraro with its great Italian MNC pedigree got hammered by the market. Goes to show that pedigree alone can't save a stock when growth slows down and valuations are aggressive. 📉

[MIT Engineers @MitEngineers]

Bonfiglioli Transmissions Limited ⚙️

The company is fundamentally excellent and I applied full force, BUT paying 45.24x Forward FY26 P/E at a ~22% GMP (~₹715) brings a major dilemma: where is the top-line growth?

• The Revenue Reality: Despite great metrics, operational top-line growth lags heavily at a single-digit 9.2% CAGR.
• The Volume Ceiling: Operations have already hit a heavy 75% capacity utilization. Because the IPO is 100% an Offer for Sale (OFS), no fresh cash enters the company to fund fast expansion.

• The Structural Trap: Paying a premium 45x forward multiple for single-digit revenue growth leaves zero margin of safety for listing-day buyers, risking an extended time correction

[MIT Engineers @MitEngineers]

I have allocated 10% of my portfolio to high-risk, new-age businesses. Within this allocation, I will apply for IPOs based on my own fundamental analysis and risk appetite, irrespective of QIB demand or overall subscription levels. I understand that these businesses carry significant risks, and I am prepared for the possibility of a listing decline

[MIT Engineers @MitEngineers]

ZETWERK IPO: NO DIRECT PEER — INDUSTRIAL DISRUPTOR OR VALUATION TRAP? 🏭📊

Zetwerk is not merely a manufacturing company. It is building a technology-led B2B manufacturing ecosystem with a differentiated business model.

🔹 PROMOTERS: First-generation entrepreneurs in their mid-30s, potentially combining experience, energy and a long execution runway.

🔹 UNIQUE BUSINESS MODEL: B2B platform + 800+ engineers + asset-light MSME manufacturing network + selective in-house factory infrastructure.

🔹 HOW IT WORKS: A data-centre company needs transformers. Zetwerk's engineers understand specifications, design the solution, allocate production to suitable manufacturing partners and manage execution. Complex processes can be handled in its own facilities.

📈 SCALE: FY26 revenue reportedly reached ₹15,913 crore, up 40.4%. Adjusted EBITDA: ₹421 crore. Reported net loss: ₹1,606 crore.

💥 WHY WAS THE FY26 LOSS SO LARGE?
The headline loss needs to be examined beyond operating performance:

Non-cash ESOP/share-based compensation: Approximately ₹800 crore of founder and employee share-based charges reportedly weighed on reported earnings. These are non-cash accounting expenses in the period, although equity compensation has an economic cost through dilution.

Civil infrastructure exit: A reported ₹450 crore write-down associated with exiting legacy civil infrastructure operations added to the loss.

Low-margin metal trading: Ring-fencing the low-margin commodity-sourcing business, reportedly operating at around 1.24% EBITDA margin, could improve transparency and focus on higher-value manufacturing. It does not automatically eliminate the underlying economic risks.

These items may explain a substantial part of the loss, but the entire ₹1,606 crore loss should not be dismissed as unreal. Recurring expenses, finance costs and cash-flow performance still matter.

💰 THE FY27 TURNAROUND THESIS
Projected FY27 PAT: ₹180–250 crore — an estimate, not a certainty.

1️⃣ Debt reduction: Approximately ₹2,160 crore of IPO proceeds is earmarked for debt repayment, potentially reducing interest costs.

2️⃣ Operating leverage: Projected adjusted EBITDA of ₹580–620 crore, assuming revenue growth and execution improvements.

3️⃣ Lower exceptional charges: FY26's civil infrastructure write-down may not recur at the same level, although future ESOP expenses and other charges remain possible.

Illustrative bridge: ₹580–620 crore adjusted EBITDA, less ₹110–130 crore finance costs, ₹180–200 crore depreciation and other charges, and ₹30–50 crore estimated tax, supports a potential positive PAT—subject to actual accounting and tax treatment.

🔍 POTENTIAL PEER FRAMEWORK — NOT DIRECT COMPARABLES
Dixon Technologies: A reference point for the EMS/manufacturing side of the business.
Delhivery: A reference point for the technology-led platform-plus-infrastructure side.
Zetwerk sits somewhere between these two business architectures. It combines engineering-led custom manufacturing, a distributed MSME partner ecosystem and selective owned production infrastructure. There is no obvious like-for-like listed global peer.

🎯 WHO SHOULD CONSIDER THIS IPO?
In my view, this may not be suitable for retail investors with limited funds or low risk tolerance. It may interest HNIs and financially sophisticated investors who understand the business, can tolerate substantial volatility and are willing to underwrite a differentiated but still unproven profitability trajectory.

A three-year investment thesis would rest on successful debt reduction, sustained growth, improving margins and conversion of EBITDA into PAT and operating cash flow. This is a high-risk thesis—not a guaranteed three-year wealth creator.

MY TAKE: A potentially unique industrial platform with considerable upside if execution succeeds, but valuation, working capital and profitability remain the critical tests.

DISCLAIMER — FOR SEBI COMPLIANCE: This post is for educational and informational purposes only. It is not investment advice, a research report, a buy/sell recommendation or a solicitation to invest. The views expressed are analytical opinions, not a recommendation to any specific investor category. All financial figures and projections require independent verification against the RHP, audited financial statements and stock-exchange disclosures. Forward-looking estimates are uncertain and actual outcomes may differ materially. No assurance of returns or profitability is given. Investors should assess their own financial circumstances, risk tolerance and investment horizon and consult a SEBI-registered investment adviser where appropriate. Securities investments are subject to market risks, including possible loss of capital.

[MIT Engineers @MitEngineers]

Zetwerk IPO: A Business That Defies Easy Valuation.

Spent considerable time today understanding Zetwerk’s business model and valuation.

It’s a unique business, and finding the right peer for comparison is surprisingly difficult.

A few interesting insights emerged when I looked beyond the headline numbers.

Will share my analysis tomorrow—with logic, figures and some unconventional valuation perspectives.

Sometimes, the most interesting IPOs are the hardest to value.

[MIT Engineers @MitEngineers]

Zetwerk IPO: A Business That Defies Easy Valuation.

Spent considerable time today understanding Zetwerk’s business model and valuation.

It’s a unique business, and finding the right peer for comparison is surprisingly difficult.

A few interesting insights emerged when I looked beyond the headline numbers.

Will share my analysis tomorrow—with logic, figures and some unconventional valuation perspectives.

Sometimes, the most interesting IPOs are the hardest to value.

[MIT Engineers @MitEngineers]

Vibhav Vyappar 👀 | High risk, interesting possibility
The IPO saw weak subscription, and risks are real: a small lending player focused on unsecured loans could face stress from rising interest rates, defaults and funding constraints.

Yet, a few possibilities make this worth tracking over the long term—if management executes well.

• IPO proceeds could take net worth to ~₹90 Cr, potentially supporting ~2× leverage and a lending book of ~₹270–300 Cr, subject to actual capital availability and regulatory constraints.

• Current borrowing costs of ~17% could potentially decline if improved creditworthiness enables NCD funding at 12–13%, supporting better interest spreads. This is a possibility, not a certainty.

• GetFive Merchant Bankers’ previous IPOs, including iWare TeamTech and EPW, have been encouraging so far. It will be interesting to see how Vibhav Vyappar executes.

The thesis is execution-dependent, not a prediction. Funding costs, credit quality, collections and capital access will be key to watch.

Disclosure: I have been allotted shares in this IPO, which may create a potential conflict of interest and bias my views. This post reflects personal observations, not investment advice, a recommendation to buy/sell/hold, or a solicitation. The figures and scenarios mentioned are indicative and subject to verification; outcomes are uncertain. Please review the offer documents, assess the risks independently and consult a SEBI-registered investment adviser if needed. Investments in securities are subject to market risks; read all related documents carefully. Past performance does not guarantee future results.

[MIT Engineers @MitEngineers]

Twitter is divided on Fusion CX, Ravita Engineering & Vaibhav Vyapaar.

Some see red flags. Others see opportunity. And that’s the beauty of investing. 👇

The same information can lead to opposite decisions. At the same price, one investor wants to sell, while another sees value and wants to buy.

I’ve already shared the fundamentals of all three IPOs. 📊 But there are a few less obvious factors beyond the fundamentals that could shape their listing-day performance. 👀

I’ll share my views on these points soon. Agree or disagree, let’s debate! 🧵

Disclaimer: I’ve applied for all three IPOs. These are my personal views, not investment advice. Do your own research.

[MIT Engineers @MitEngineers]

Shellz India IPO 🍬: Doubling Capacity Before Fixing Utilisation?

There’s plenty of positive commentary and some reputed names in the anchor book. But a balanced discussion must highlight the red flags too. A strong anchor book doesn’t make business risks disappear. Let’s discuss both sides before forming an opinion.

🚩 Key concerns: • FY26 revenue growth: just 3% • EBITDA margin jumped to 15.7%, but operating cash flow was -₹11.3 Cr • Existing plant utilisation: only 66.5% • Inventory days: 126 → 187 • Debt/equity: 1.71x • ₹22.2 Cr goodwill; ₹20.8 Cr disputed tax demands

🏭 The big operational risk: Manufacturing is planned to shift from Delhi to Sonipat, Haryana. Production interruptions, transition costs, logistics changes and delays could affect supply and profitability.

Capacity is set to rise from 17,100 MT to 34,500 MT, yet the RHP gives no clear commissioning or ramp-up timeline.

Key question: Why nearly double capacity when the existing plant is only ~67% utilised?

⚠️ Disclaimer: For educational purposes only. Not investment advice or a buy/sell recommendation. Figures are based on the RHP and cited IPO disclosures; verify independently before investing.DYDD

[MIT Engineers @MitEngineers]

Corporate Governance Noise vs. Execution Reality: The Turning Point for Ravita Engineering
Market sentiment is heavily split between the corporate governance noise—the Jan 2026 ED raid at Ganesh Infraworld and delayed disclosure—and the sheer execution reality at Ravita Engineering Services under the same promoter, Vibhoar Agrawal.

but what makes this case truly fascinating is the operational turnaround. By retaining the core technical team and key leadership post-takeover, the new management preserved crucial execution stability. This continuity transformed the firm into a full-scale EPIC player, driving revenue to ₹278 Cr (FY26) with a ₹491 Cr order book. The fundamentals tell a story that corporate headlines simply can't ignore.

Both arguments are rock solid. Whether the technical execution can outrun the promoter's regulatory noise is the real puzzle that will decide the listing. Time will tell.

Disclaimer: I am not a SEBI-registered investment advisor. The insights shared above are based on publicly available corporate disclosures and are meant strictly for informational and educational purposes. They do not constitute financial, legal, or investment advice. Investing in small and medium enterprises (SMEs) and IPOs involves extreme market risks, including corporate governance exposures and liquidity constraints. Please perform your own exhaustive due diligence and consult a certified financial advisor before committing capital.

[MIT Engineers @MitEngineers]

Twitter is divided on Fusion CX, Ravita Engineering & Vaibhav Vyapaar.

Some see red flags. Others see opportunity. And that’s the beauty of investing. 👇

The same information can lead to opposite decisions. At the same price, one investor wants to sell, while another sees value and wants to buy.

I’ve already shared the fundamentals of all three IPOs. 📊 But there are a few less obvious factors beyond the fundamentals that could shape their listing-day performance. 👀

I’ll share my views on these points soon. Agree or disagree, let’s debate! 🧵

Disclaimer: I’ve applied for all three IPOs. These are my personal views, not investment advice. Do your own research.

[MIT Engineers @MitEngineers]

🚀 FusionCX IPO Closed Today! 🚀
If you are looking at the long-term future of this stock, ignore the short-term noise. These 4 critical pillars will decide its trajectory: 👇

1️⃣ Promoter Stake Post-IPO 👑
Even after the fresh issue and Offer for Sale (OFS), the promoters are retaining massive skin in the game. The promoter holding will stand at a rock-solid ~81.82% post-IPO (~77.35% on a fully diluted basis), down from 98.46%. This exceptionally high majority control ensures long-term management stability and alignment with minority shareholders.

2️⃣ The M&A Acquisition Engine 🎯
Fusion CX is an aggressive, serial shopper. With 16 international boutique acquisitions under their belt since 2007 (and 6 since last year alone), they don't just wait for organic growth—they buy entry tickets straight into lucrative global sectors like Telecom and Healthcare.

3️⃣ Heavyweight Institutional Trust (75% QIB Quota) 🏛️
The issue is structurally built for big money, with a massive 75% of the quota reserved for QIBs. The anchor book is a powerhouse, backed by elite institutional names like Quant MF, Kotak Mahindra Life Insurance, and marquee HNIs like Ashish Kacholia’s Bengal Finance. When the smartest minds in the market buy in at the absolute top price band of ₹289, you pay attention.

4️⃣ Explosive & Robust Growth Metrics 📈
The financial trajectory is undeniable. Revenue scaled from ₹991 Cr (FY24) to ₹1,818 Cr (FY26), while Net Profit exploded 4.6x to ₹169.8 Cr. Driven by massive foreign inflows (88.7% export revenue), they are converting this growth into strong cash flows to become completely debt-free post-IPO.

💬 The Long View: This isn't a quick listing-gain flip. It is a fundamental compounding play backed by institutional giants, high promoter conviction, and a proven global expansion engine.

The Bear Case: The Risks I Evaluated

To stay objective, I had to look closely at the counter-arguments before hitting submit:

The AI Disruption Threat: At its core, this remains a people-heavy BPO business (employee costs eat 65.6% of revenue). Routine voice and chat tasks face long-term disruption risks from evolving Generative AI.

Acquisition Dependency: Because their growth relies heavily on international buyouts, goodwill and intangibles are their largest assets. Any future integration failures could lead to heavy balance sheet write-downs.

At-Par Valuation: At a 21.55x P/E, the IPO isn't priced at a steep discount. It sits right at par with listed industry peers like Firstsource (22.2x) and Sagility (21.6x).

💬 : For me, the massive promoter alignment, institutional backing, and debt-free status outweigh the structural BPO headwinds. This is a fundamental compounding bet on global AI operations and strategic buyouts.

Did you end up applying on the final day, or did the risks keep you on the sidelines? Let's discuss below! 👇

⚠️ SEBI Disclaimer: I am not a SEBI-registered investment advisor. This post is for educational and informational purposes only and does not constitute financial advice. Equity and IPO investments are subject to market risks. Please read the RHP thoroughly and consult your financial advisor before investing.

[MIT Engineers @MitEngineers]

Twitter is divided on Fusion CX, Ravita Engineering & Vaibhav Vyapaar.

Some see red flags. Others see opportunity. And that’s the beauty of investing. 👇

The same information can lead to opposite decisions. At the same price, one investor wants to sell, while another sees value and wants to buy.

I’ve already shared the fundamentals of all three IPOs. 📊 But there are a few less obvious factors beyond the fundamentals that could shape their listing-day performance. 👀

I’ll share my views on these points soon. Agree or disagree, let’s debate! 🧵

Disclaimer: I’ve applied for all three IPOs. These are my personal views, not investment advice. Do your own research.

[MIT Engineers @MitEngineers]

Twitter is divided on Fusion CX, Ravita Engineering & Vaibhav Vyapaar.

Some see red flags. Others see opportunity. And that’s the beauty of investing. 👇

The same information can lead to opposite decisions. At the same price, one investor wants to sell, while another sees value and wants to buy.

I’ve already shared the fundamentals of all three IPOs. 📊 But there are a few less obvious factors beyond the fundamentals that could shape their listing-day performance. 👀

I’ll share my views on these points soon. Agree or disagree, let’s debate! 🧵

Disclaimer: I’ve applied for all three IPOs. These are my personal views, not investment advice. Do your own research.

[MIT Engineers @MitEngineers]

🔍
Tonbo Imaging is launching an ₹852.18 Cr IPO (100% OFS).

While its ITAR-free electro-optics tech is highly advanced, Here is a breakdown of the key factors.

👇Tonbo Imaging India IPO Investment Note

📊 The Core Metrics:
• Peer Comparison: Revenue fell 22.7% & PAT dropped 30.1% in FY26. Pure-play defense peers (Data Patterns, Paras) show much stronger growth.

• Promoter Stake: Founders hold just 17.43% pre-IPO, dropping to ~14.6% post-IPO. Extremely low "skin in the game".

• Asset Efficiency: Asset-light model means outsourcing assembly to contract manufacturers. Net Fixed Asset Turnover is high at 14.6x, but working capital stretched to a massive 517 days.

3/3 ⚠️ Valuation & Order Book:
• Order Book: Stood at ₹314.24 Cr—only 0.87x of FY26 revenue, providing weak visibility.

• Valuation: Priced at ₹665–₹700, translating to a steep 78.83x P/E on FY26 earnings.

• Recent Trend: Slipped into a net loss of -₹17.74 Cr in Q1 FY27.

(Disclaimer: This is a personal investment note for educational/informational purposes only. Not financial advice. Please consult a SEBI-registered advisor before investing.)

[MIT Engineers @MitEngineers]

@Arpit296 Thank you for your appreciation, dear! 😊
I have already covered both SME IPOs closing on the 15th and 16th.

[MIT Engineers @MitEngineers]

HD Fire Protect IPO: Deep-Dive Note 🧯

• The Moat: India’s top industrial safety exporter with a massive certification barrier (21 UL / 87 FM approvals).

• The Trap: Total asset turnover drops to 1.13x (vs ~4.7x fixed asset turnover) due to a 102-day working capital lock-up and a huge ₹188Cr cash drag.

• The Mix: Capacity utilization slid to 63.4%, but revenue rose as production shifted to low-volume, high-value customized systems.

• The Friction: Pricing sits at a demanding ~40.7x P/E despite a ~15.2% PAT CAGR, as bottom-line growth slowed heavily to 6.4% in FY26.

• The Cushion: Completely debt-free with a strong 30.75% EBITDA margin and highly resilient, robust Cash Flow from Operations (~₹92.5Cr).

Disclaimer: For educational purposes only. Not financial advice. Read the RHP before investing.

[MIT Engineers @MitEngineers]

At SJP Ultrasonic’s IPO, we discussed how long-term UHNI investors matter more than QIBs chasing GMP & subscription data. The outcome reinforced our conviction.

Before a separate QIB quota, many good SME companies still created multibagger returns for investors.

Merge the QIB quota with BHNI, retain the Anchor quota, and keep SHNI & Retail quotas unchanged.

Let conviction-driven investors back quality businesses with meaningful allocations.

SME IPO reform must reward fundamental analysis, not GMP-driven subscription frenzy.

[MIT Engineers @MitEngineers]

@dhruv_rathee Then unit

[MIT Engineers @MitEngineers]

Bonfiglioli Transmissions IPO Deep-Dive: Financial Marvel or Promoter Cash-Out? 🚨

🐂 The Bull Case: An Asset-Light Engineering Powerhouse

Unmatched Machine Efficiency: Boasts a spectacular Fixed Asset Turnover of 7.2x—vastly outperforming the industrial engineering average of ~4.0x due to a highly optimized, localized assembly model.

Premium Returns: The business commands a stellar 34% ROCE and strong operating margins that expanded to 19.8% in H1CY26.

Production Headroom: Operates at ~75% capacity utilization, giving it plenty of room to scale without requiring immediate, heavy capital expenditure.

🐻 The Bear Case: The Working Capital & Governance Friction

. The real bottleneck isn't factory capacity—it is a sluggish Working Capital Cycle locked up in high inventory days (~90 days) and long debtor cycles (~80 days) dictated by powerful OEM clients.The Turnover Illusion: While fixed asset turnover is great, the Total Asset Turnover drops to 1.51x

Zero Growth Capital: The issue is a 100% Offer for Sale (OFS). The entire ₹2,533 Cr goes straight to the Italian promoters. The company receives ₹0 to support its ballooning working capital needs as it expands.

🔍 The Hidden Risk Everyone is Ignoring: The Royalty Drain

High Promoter Outflow: Bonfiglioli India pays a steep 4.5% annual royalty to its Italian parent—up from 4.2% in CY22.

Peer Comparison: Standard MNC peers listed in India (like Bosch, ABB, and Schaeffler) typically cap parent royalties between 2% to 3%.

The Reality: This 4.5% rate siphons roughly ₹90 Cr annually out of the Indian listed entity. Because the parent is using this IPO to extract capital rather than invest it, any future upward revisions to this royalty agreement present a silent dilution risk for public shareholders.

At a forward P/E of 37.07x, it is priced reasonably against the industry average (51.61x), but investors must weigh excellent operating efficiency against structural cash extraction.

⚠️ SEBI Disclaimer: I am not a SEBI registered investment advisor. This analysis is purely for educational and informational purposes based on the Red Herring Prospectus (RHP) and publicly available broker notes. This is not financial advice or a recommendation to buy, sell, or subscribe to the IPO. Please consult a certified financial advisor before making any investment decisions.

[MIT Engineers @MitEngineers]

SMT IPO: High-Barrier Medical Asset or Working Capital Trap? 🚨

🟢 The Bull Case (The Moat & Smart Money):
Global Validation: Holds a massive 25% domestic market share and ranks as a top-5 stent brand in Germany & Spain, exporting to 77 countries.

Pure R&D Engine: Reinvests an aggressive 8.6% of revenue back into R&D with 119 granted global patents to sustain its future pipeline.

Marquee Backing: Pre-IPO rounds saw anchor entries by institutional giants like WhiteOak, Malabar, and Ashish Kacholia .

🔴 The Risks (Where the Friction Lies):

1️⃣ The Cash Gap: Despite a ₹69.08 Cr PAT turnaround in FY26, Q1 FY27 recorded a Negative Operating Cash Flow of -₹22.21 Cr. Strained by long hospital receivable cycles.

2️⃣ Capital Intensive: SMT operates at an asset turnover under 0.95x. Every ₹1 in advanced machinery generates under ₹1 in sales—it is a heavy manufacturing drag.

3️⃣ Debt Profile: Total borrowings climbed to ₹320.63 Cr in Q1 FY27. Since the IPO is a 100% OFS, no fresh capital enters to clear this debt.

Priced aggressively at 57.91x P/E, SMT mimics global giants like Medtronic in its tech complexity but faces structural balance sheet friction. This is an elite category builder meant strictly for patient, long-term compounders—not short-term listing gains.

🛑 CRITICAL SEBI DISCLAIMER & SAFETY NOTICE:
NOT FINANCIAL ADVICE: This post is strictly for educational, informational, and case-study purposes only. It does NOT constitute a buy, sell, subscribe, or hold recommendation.
MARKET RISK: Investments in the securities market are subject to high market risks. Equity investments, especially unlisted or newly listing IPOs, carry a risk of total capital loss. Read all Red Herring Prospectus (RHP) and offer-related documents carefully before executing any financial transaction.
Past performance is never an indicator of future results. The creator accepts no liability for any financial losses incurred.